Hudson Bay Capital Management
IMCR icon

Hudson Bay Capital Management’s Immunocore IMCR Stock Holding History

Hudson Bay Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Sell
590,000
-43,174
-7% -$1.28M 0.05% 232
2026
Q1 		$19.1M Buy
633,174
+249,616
+65% +$8.08M 0.07% 201
2025
Q4 		$13.3M Buy
383,558
+50,000
+15% +$1.77M 0.04% 286
2025
Q3 		$12.1M Sell
333,558
-12,394
-4% -$421K 0.04% 316
2025
Q2 		$10.9M Sell
345,952
-49,382
-12% -$1.53M 0.04% 338
2025
Q1 		$11.7M Buy
395,334
+70,034
+22% +$2.1M 0.04% 361
2024
Q4 		$9.6M Buy
325,300
+78,000
+32% +$2.47M 0.03% 370
2024
Q3 		$7.7M Buy
247,300
+54,121
+28% +$1.97M 0.03% 341
2024
Q2 		$6.55M Buy
+193,179
New +$9.85M 0.03% 324

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Hudson Bay Capital Management's IMCR Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Immunocore (IMCR) stake by 6.8% in Q2 2026, selling an estimated $1.28M and leaving 590,000 shares worth $18.7M. The position accounts for 0.05% of the portfolio, ranked #232.

Hudson Bay Capital Management first reported a position in IMCR in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.1M in Q1 2026. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Hudson Bay Capital Management held 590,000 shares of Immunocore worth $18.7M as of Q2 2026.
  • Hudson Bay Capital Management sold 43,174 Immunocore shares in Q2 2026, an estimated $1.28M.
  • Immunocore made up 0.05% of Hudson Bay Capital Management's portfolio in Q2 2026, its #232 holding.
  • Hudson Bay Capital Management first reported a position in Immunocore in Q2 2024 and has held it in 9 quarters since.
  • Hudson Bay Capital Management's Immunocore position peaked at $19.1M in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.